LAB Token Lock-Up Until 2027 Raises Liquidity Concerns

KuCoinFlash

Release Time: 06/04/2026 13:52:45

LAB

$12.49949-15.57%

Summary

On-chain data from Bubblemaps shows that LAB tokens remain locked until 2027, with the first unlock scheduled for July 14. Originally sold to 313 investors for $1.428 million, the tokens now have an on-chain value of $977 million. Liquidity concerns have emerged due to the high concentration of tokens and extended lockup period. Bubblemaps cautions that large-scale selling following the unlocks could exert downward pressure on the market, given $1 billion in unrealized gains.

Odaily Planet Daily report: On-chain data platform Bubblemaps has released on-chain data analysis for the LAB token, revealing that only 313 participants took part in the presale on the Legion platform, with a total initial investment of approximately $1.428 million. The current market value of these presale tokens has surged to $977 million, bringing the investors' total unrealized gains close to $1 billion.

Subject to lock-up rules, investors' full share lock-up periods extend until 2027, making funds difficult to liquidate; only on July 14 did the first batch of tokens become unlockable. Bubblemaps noted that the highly concentrated token distribution combined with a long-term lock-up economic model poses significant liquidity risks, and the market generally fears that subsequent rounds of unlockings could lead to concentrated selling of large profit-taking positions, pressuring market prices.

Source:Show original

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.